Ensysce Biosciences, Inc. (ENSC): auditor change — Ensysce Biosciences dismisses Mayer Hoffman McCann, appoints Moss Adams as auditor

Ensysce Biosciences, Inc.

Appointed Moss Adams LLP as independent registered public accounting firm effective April 10, 2023.
Dismissed former auditor Mayer Hoffman McCann P.C. (MHM) effective the same date.
No disagreements or reportable events with MHM during 2021-2022 or interim period.
MHM's audit reports included explanatory paragraph about substantial doubt on company's going concern.
MHM letter filed as Exhibit 16 concurring with company's disclosures.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Ensysce Biosciences, Inc. dismissed Mayer Hoffman McCann P.C. as its auditor.

Action: dismissal
Auditor: Mayer Hoffman McCann P.C.
Successor: Moss Adams LLP

Exact text from the filing

pon the appointment of Moss Adams our former auditor, Mayer Hoffman McCann P.C. (“ MHM ”) was dismissed as the independent registered public accounting firm for Ensysce Biosciences, Inc.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Ensysce Biosciences, Inc. engaged Moss Adams LLP as its auditor.

Action: engagement
Auditor: Moss Adams LLP

Exact text from the filing

n April 10, 2023, upon the approval of the Audit Committee of the Company’s Board of Directors, the Company engaged Moss Adams LLP (“ Moss Adams ”) to serve as the Company’s independent registered public accounting firm, effective April 10, 2023 (the “ Engagement Date ”). During the fiscal years ended December 31, 2022 and 2021 and the subsequent interim period through the Engagement Date, neither the Company nor anyone acting on its behalf consulted Moss Adams regarding either: (1) application of accounting principles to any specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s consolidated financial statements, and neither a written report nor oral advice was provided to the Company by Moss Adams that Moss Adams concluded was an important factor considered by the Company in reaching a decision as to such accounting, au

View on SEC.gov

8 auditor changes filed in the last 30 days. Browse all auditor changes →

Ensysce Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-011751

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.